UBS Group Initiates Coverage on enGene (NASDAQ:ENGN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Shares of NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) saw strong trading volume on Tuesday . 195,163 shares changed hands during trading, a decline of 19% from the previous session’s volume of 239,915 shares.The stock last traded at $22.48 and had previously closed at $22.46. Analyst Ratings Changes A number of research firms have recently […]
Replimune Group (NASDAQ:REPL) Trading Up 5.3% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Dyne Therapeutics (NASDAQ:DYN – Free Report) had its price target hoisted by Chardan Capital from $20.00 to $31.00 in a research note issued to investors on Friday, Stock Target Advisor reports. The brokerage currently has a buy rating on the stock. Several other research firms have also weighed in on DYN. StockNews.com upgraded shares of […]
Morgan Stanley started coverage on shares of enGene (NASDAQ:ENGN – Free Report) in a research note published on Friday, MarketBeat reports. The brokerage issued an overweight rating and a $40.00 target price on the stock. ENGN has been the topic of several other reports. Leerink Partnrs reaffirmed an outperform rating on shares of enGene in […]